Denali Therapeutics (DNLI) Q2 2024 Earnings

May 7Confirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.86
-0.14
0.58
1.3

Details

Expected EPS
-0.694924
Actual EPS
-0.68
Surprise EPS
0.01
Surprise Percent
+2.15%

Description

⁨Denali Therapeutics⁩ (⁦DNLI⁩) has reported earnings of ⁦-0.68⁩ per share for ⁦Q2 2024⁩.

0 Comments

Share your thoughts